SC 13D

LANCE ALSTODT SCHEDULE 13D

Company: BioRestorative Therapies, Inc.
Filed: March 19, 2021
Accession Number: 0001021771-21-000022

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →

View Document ↗ View on SEC.gov ↗